- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Holding(s) in Company
- OBD pursuing EpiSwitch as companion diagnostics
- Grant of Options
- Half-year Report
- OBD's PSE test to be used in NCI trial
- OBD develops multi-cancer diagnostic test for dogs
- Notice of Results
- OBD partners with Goodbody Clinic on PSE test
- OBD partners with The London Clinic for PSE & CiRT
- OBD and King's College London collaborate on RA
More ▼
Key statistics
On Friday, Oxford Biodynamics PLC (OBD:LSE) closed at 3.19, 13.93% above the 52 week low of 2.80 set on Sep 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.24 |
---|---|
High | 3.50 |
Low | 3.14 |
Bid | 3.19 |
Offer | 3.50 |
Previous close | 3.20 |
Average volume | 2.44m |
---|---|
Shares outstanding | 311.86m |
Free float | 266.47m |
P/E (TTM) | -- |
Market cap | 9.98m GBP |
EPS (TTM) | -0.0643 GBP |
Data delayed at least 20 minutes, as of Sep 27 2024 16:35 BST.
More ▼